These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11864958)

  • 1. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli.
    Qiang YZ; Qin T; Fu W; Cheng WP; Li YS; Yi G
    J Antimicrob Chemother; 2002 Mar; 49(3):549-52. PubMed ID: 11864958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Mismatch Amplification Mutation Assay PCR and PCR-Restriction Fragment Length Polymorphism for Detection of Major Mutations in gyrA and parC of Escherichia coli Associated with Fluoroquinolone Resistance.
    Jazeela K; Chakraborty G; Shetty SS; Rohit A; Karunasagar I; Vijaya Kumar D
    Microb Drug Resist; 2019; 25(1):23-31. PubMed ID: 30036132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae.
    Hashemi B; Abdollahi M; Rafiei A; Pormohammad A; Ahanjan M; Moghadaszadeh M; Rashidian S
    Microb Pathog; 2018 Jul; 120():181-186. PubMed ID: 29742463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
    Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Detection of Genomic Mutations in gyrA and parC Genes of Escherichia coli by Multiplex Allele Specific Polymerase Chain Reaction.
    Onseedaeng S; Ratthawongjirakul P
    J Clin Lab Anal; 2016 Nov; 30(6):947-955. PubMed ID: 27075845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
    Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
    J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U; Ray K; Bala M; Saluja D
    Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Quinolone-Resistant Mutations of gyrA and parC Genes after Pouchitis Treatment with Ciprofloxacin.
    Fukushima K; Saito T; Kohyama A; Watanabe K
    Dig Surg; 2020; 37(4):321-330. PubMed ID: 32182609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ciprofloxacin-resistant Salmonella strains from swine, chicken, and their carcasses in Taiwan and detection of parC resistance mutations by a mismatch amplification mutation assay PCR.
    Lin CC; Chen TH; Wang YC; Chang CC; Hsuan SL; Chang YC; Yeh KS
    J Food Prot; 2009 Jan; 72(1):14-20. PubMed ID: 19205458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
    Heisig P
    Antimicrob Agents Chemother; 1996 Apr; 40(4):879-85. PubMed ID: 8849244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
    Zirnstein G; Helsel L; Li Y; Swaminathan B; Besser J
    FEMS Microbiol Lett; 2000 Sep; 190(1):1-7. PubMed ID: 10981681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.